Search Results
Results found for "chronic pain"
- Dr. Kevin Pfleger and Dr. Elizabeth Johnstone were awarded one of the 2022 Diabetes Research...
Endocrinology and Pharmacology Laboratory team who are investigating new ways to tackle the disease-inducing chronic
- Unlock the Future of GPCR Science: Breakthroughs and Courses Await | Sep 2 - Sep 8, 2024
Don't miss this fantastic opportunity to gain valuable knowledge and prepare for the forthcoming sessions Therapeutic Targets for the Treatment of Neurological Disease s Activation of GPR55 alleviates neuropathic pain and chronic inflammation Developmental exposures to common environmental pollutants result in long-term
- Statin-induced increase in actin polymerization modulates GPCR dynamics and compartmentalization
In a recent work, we reported that chronic cholesterol depletion using statins leads to significant polymerization
- 📰 GPCR Weekly News, July 1 to 7, 2024
for their investigation on Modulation of contextual fear acquisition and extinction by acute and chronic signaling in murine brain tissue Modulation of contextual fear acquisition and extinction by acute and chronic
- C5aR2 receptor: The genomic twin of the flamboyant C5aR1
context-dependent compared to the C5aR1, which has received enormous attention for its role in both acute and chronic
- 📰 Breaking Down the Latest GPCR Discoveries: a Weekly Update (Nov 27-Dec 3, 2023)
revealed by 19F NMR spectroscopy Role of protease activated receptor 4 (PAR4) in mouse models of acute and chronic protein and fat synthesis GPCRs in Neuroscience Targeting sensory neuron GPCRs for peripheral neuropathic pain Expression prevalence and dynamics of GPCR somatostatin receptors 2 and 3 as cancer biomarkers beyond NET: a paired
- GPR15 expressed in T lymphocytes from RA patients is involved in leukocyte chemotaxis to the...
Recent evidence indicates that GPR15 may be associated with modulation of the chronic inflammatory response
- 📰 GPCR Weekly News, June 17 to 23, 2024
Trevena Announces Preclinical TRV045 Data Providing Insight Into Novel Mechanism of Analgesic Effect in Chronic Neuropathic Pain Model and Demonstrating Statistically Significant Anti-Seizure Activity in Epilepsy
- How Understanding Intracellular Drug Access Can Transform Your GPCR Drug Discovery Program
Industry insights: Crinetics' Palsonify gains momentum in acromegaly, a key indicator for pipeline expansion ; Septerna's chart signals upward expansion; and a look at how chronic diseases are driving growth in Gain a competitive edge: Learn to leverage restricted diffusion and rebinding to create drugs with longer
- 📰 GPCR Weekly News
GPCR Activation and Signaling Targeting GRK2 and GRK5 for treating chronic degenerative diseases: Advances
- Involvement of various chemokine/chemokine receptor axes in trafficking and oriented locomotion ...
mesenchymal stem cells in multiple sclerosis patients Multiple sclerosis (MS) is a specific type of chronic
- 📰 GPCR Weekly News, October 2 to 8, 2023
GPCR Function Interplay of Cholesterol and Actin in Neurotransmitter GPCR Signaling: Insights from Chronic
- Unlocking the Future of Medicine: Advancements in GPCR Research
It is an opportunity to connect with like-minded scientists and researchers and gain valuable insights regulation of beige adipocyte formation: Implications for obesity and metabolic health GPCRs in Neuroscience Chronic
- 📰 GPCR Weekly News, August 7 to 13, 2023
Reports Second-Quarter 2023 Financial Results, Provides Corporate Updates, and Reports Emerging Data from Chronic
- Chemokine receptor-targeted drug discovery: progress and challenges
inappropriate target selection and insufficient dosing of chemokine receptor antagonists in vivo might be the main rigorous for this class, as the majority of potential therapeutic applications are situated in the area of chronic
- Exploring the Breakthroughs in GPCR Research
Drivers of BCR-ABL1-Independent Imatinib Resistance and Six Herbal Compounds as Potential Drugs for Chronic
- 📰 GPCR Weekly News, May 20 to 26, 2024
protein-coupled receptor-associated proteins in the caudate and the putamen of cynomolgus macaques following chronic
- APEX2/AUR Biosensor: A Powerful Tool for Protein Interaction and Trafficking
trafficking of DOR, facilitating its downregulation and influencing cellular signaling pathways essential for pain As the opioid crisis continues to challenge public health, insights gained from this research could inform
- Targeting GPCRs in the CNS: Advances in Drug Discovery Strategies
The activation of these pathways regulates pain modulation, memory consolidation, motor coordination neuroprotective functions and is now being investigated for its role in Parkinson’s disease and neuropathic pain Of the traditional GPCRs, CBRs are gaining ground as potential therapeutic targets in several CNS diseases
- Inside Out: Mapping GPCRs from Membrane Codes to Market Moves
studies reveal how phosphorylation barcodes shape arrestin engagement, a biased NTSR1 modulator targets pain Barcodes Shape Arrestin Engagement with ACKR3 A β-Arrestin-2-Biased NTSR1 Modulator for Non-Addictive Pain
- Specific Functions of Melanocortin 3 Receptor (MC3R)
In addition to its function about weight gain and appetite control mechanisms of MC3R, recent studies In this review paper, we aimed to point out the importance of the MC3R regulations in three main concepts
- Mechanism vs. Assumption: A Model-First Path to Getting GPCR MoA Right
Must-read publications: β-arrestin2-biased allosteric modulator for pain beyond opioids & GPR3 regulated What you’ll gain—immediately relevant to your pipeline: Stop costly misreads: Distinguish orthosteric
- 🎄 Have Yourself a Merry Little GPCRmas! ❄ Dec 9 - 15, 2024
of the proton-sensing GPCR, GPR65 on fibroblast-like synoviocytes contributes to inflammatory joint pain of the proton-sensing GPCR, GPR65 on fibroblast-like synoviocytes contributes to inflammatory joint pain
- Exploring pharmacological inhibition of G q/11 as an analgesic strategy
has pro-nociceptive properties, suggesting that blockade of Gq/11 signalling could be beneficial for pain Experimental approach: We used a series of behavioural assays to evaluate the acute responses of mice to painful
- Coincident Regulation of PLCβ Signaling by Gq-Coupled and μOpioid Receptors Opposes Opioid- Mediated
Regulation of PLCβ Signaling by Gq-Coupled and μOpioid Receptors Opposes Opioid- Mediated Antinociception "Pain The current frontline approach for pain-management is the use of opioid analgesics.
- Opioid Receptors and Protonation-Coupled Binding of Opioid Drugs
receptors are G-protein-coupled receptors (GPCRs) part of cell signaling paths of direct interest to treat pain Pain may associate with inflamed tissue characterized by acidic pH. The potentially low pH at tissue targeted by opioid drugs in pain management could impact drug binding
- Fentanyl activates ovarian cancer and alleviates chemotherapy-induced toxicity via opioid...
EGFR "Background Fentanyl is an opioid analgesic and is widely used in ovarian cancer patients for pain
- Developing the Cannabinoid Receptor 2 (CB2) pharmacopoeia: past, present, and future
preclinical data supports the applicability of CB2 activation in autoimmune and inflammatory diseases, pain
- Developing the Cannabinoid Receptor 2 (CB2) pharmacopeia: past, present, and future
preclinical data support the applicability of CB2 activation in autoimmune and inflammatory diseases, pain
- Discover the Hottest GPCR News of the Week: Oct 7-13, 2024!
What are the main objectives of the course? What will students gain from taking this course? Neuroscience Ventral tegmental area amylin / calcitonin receptor signaling suppresses feeding and weight gain












